Roy Galvin

Companies

• HaemoneticsEVP, Chief Commercial Officer Jun 13, 2025 to now¹
• HaemoneticsPresident Oct 17, 2022 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Haemonetics HAE39,882 shares³$4.7M at $118.98May 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 15, 2026Granted 27,535 shares of Haemonetics³
• May 15, 2026Shares withheld for tax 879 shares at $56.29 of Haemonetics³
• Oct 31, 2025Shares withheld for tax 145 shares at $50.01 of Haemonetics⁴
• May 16, 2025Shares withheld for tax 257 shares at $70.31 of Haemonetics⁵
• May 16, 2025Granted 5,689 shares of Haemonetics⁶
• May 16, 2025Granted 6,755 shares of Haemonetics⁷
• May 15, 2025Shares withheld for tax 201 shares at $69.38 of Haemonetics⁵
• Nov 1, 2024Shares withheld for tax 161 shares at $71.48 of Haemonetics⁸
• May 17, 2024Granted 2,872 shares of Haemonetics⁹
• May 15, 2024Shares withheld for tax 214 shares at $96.49 of Haemonetics¹⁰
• Nov 1, 2023Shares withheld for tax 160 shares at $86.39 of Haemonetics¹¹
• May 15, 2023Granted 2,243 shares of Haemonetics¹²
• Nov 1, 2022Granted 2,382 shares of Haemonetics¹³